How EuBiologics' Cholera Vaccine is Driving Profits: Insights for Investors
AI 요약 정보
- Yuho projects EuBiologics sales of 135 billion KRW this year
- EuBiologics expects H2 gains as cholera vaccine shipments begin
- EuBiologics files Phase 2 shingles and Phase 1 Alzheimer’s INDs